NCI Cancer Bulletin: A Trusted Source for Cancer Research News
NCI Cancer Bulletin: A Trusted Source for Cancer Research News
March 30, 2004 • Volume 1 / Number 13 E-Mail This Document  |  View PDF Version  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
Striking Results Achieved in Lymph System Imaging

Director's Update
Enabling Technologies Will Help Pave Way to 2015

HHS News

Funding Opportunities

Cancer Research Highlights
Aspirin Protective Against Prostate Cancer, Study Suggests

High Levels of Vitamin E in the Blood Are Linked to a Lower Risk of Prostate Cancer

Abortion or Miscarriage Do Not Increase Risk of Developing Breast Cancer

Boosting Event-Free Survival in Some Patients with Aggressive NHL

Combining Cancer Vaccines with Conventional Therapies

Featured Clinical Trial
Four Schedules of Adjuvant Chemotherapy for Breast Cancer

Notes
PCP Urges Increased Services for Native Americans

BIO President Discusses Partnership Between Industry and NCI

Scientists Highlight Insights from Chemical Approaches to Biology and Genomics

Featured Meetings

Bulletin Archive

Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
PDF Version  View/Print PDF
Funding Opportunities


More AACR Meeting News

Look for more research highlights from the 95th annual meeting of the American Association for Cancer Research in next week's NCI Cancer Bulletin.

Understanding and Preventing Brain Tumor Dispersal
PAS-04-079
Application Receipt Dates: June 1, 2004;
Oct. 1, 2004; Feb. 1, 2005; June 1, 2005;
Oct. 1, 2005; Feb. 1, 2006; June 1, 2006;
Oct. 1, 2006; Feb. 1, 2007; June 1, 2007

The goal of this Program Announcement with set-aside funds (PAS) is to promote studies that 1) identify the causes of brain tumor cells dispersal, 2) determine the interactions of migrating tumor cells with normal brain elements, and 3) develop interventions that target invading tumor cells. Interdisciplinary studies that apply new concepts and methodologies from developmental neuroscience, genomics, precursor cell biology, and other related fields to the analysis of tumor spread are particularly encouraged.

This PAS will use the NIH research project grant (R01) and exploratory/developmental grant (R21) award mechanisms.

For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=1960.

Inquiries: Dr. Steven Krosnick, krosnicks@mail.nih.gov

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov